BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 27860036)

  • 1. Frailty is common and strongly associated with dyspnoea severity in fibrotic interstitial lung disease.
    Milne KM; Kwan JM; Guler S; Winstone TA; Le A; Khalil N; Camp PG; Wilcox PG; Ryerson CJ
    Respirology; 2017 May; 22(4):728-734. PubMed ID: 27860036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severity and features of frailty in systemic sclerosis-associated interstitial lung disease.
    Guler SA; Kwan JM; Winstone TA; Milne KM; Dunne JV; Wilcox PG; Ryerson CJ
    Respir Med; 2017 Aug; 129():1-7. PubMed ID: 28732817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases.
    Cheng JZ; Wilcox PG; Glaspole I; Corte TJ; Murphy D; Hague CJ; Ryerson CJ
    Respirology; 2017 Nov; 22(8):1592-1597. PubMed ID: 28544079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation and minimum important difference of the UCSD Shortness of Breath Questionnaire in fibrotic interstitial lung disease.
    Chen T; Tsai APY; Hur SA; Wong AW; Sadatsafavi M; Fisher JH; Johannson KA; Assayag D; Morisset J; Shapera S; Khalil N; Fell CD; Manganas H; Cox G; To T; Gershon AS; Hambly N; Halayko AJ; Wilcox PG; Kolb M; Ryerson CJ
    Respir Res; 2021 Jul; 22(1):202. PubMed ID: 34238283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression and functional status are strongly associated with dyspnea in interstitial lung disease.
    Ryerson CJ; Berkeley J; Carrieri-Kohlman VL; Pantilat SZ; Landefeld CS; Collard HR
    Chest; 2011 Mar; 139(3):609-616. PubMed ID: 20688924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and prognostic impact of physical frailty in interstitial lung disease: A prospective cohort study.
    Farooqi MAM; O'Hoski S; Goodwin S; Makhdami N; Aziz A; Cox G; Wald J; Ryerson CJ; Beauchamp MK; Hambly N; Kolb M
    Respirology; 2021 Jul; 26(7):683-689. PubMed ID: 33876511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body composition, muscle function, and physical performance in fibrotic interstitial lung disease: a prospective cohort study.
    Guler SA; Hur SA; Lear SA; Camp PG; Ryerson CJ
    Respir Res; 2019 Mar; 20(1):56. PubMed ID: 30866948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression is a common and chronic comorbidity in patients with interstitial lung disease.
    Ryerson CJ; Arean PA; Berkeley J; Carrieri-Kohlman VL; Pantilat SZ; Landefeld CS; Collard HR
    Respirology; 2012 Apr; 17(3):525-32. PubMed ID: 22221976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity and Reliability of the Fatigue Severity Scale in a Real-World Interstitial Lung Disease Cohort.
    Aronson KI; Martin-Schwarze AM; Swigris JJ; Kolenic G; Krishnan JK; Podolanczuk AJ; Kaner RJ; Martinez FJ; Safford MM; Pinheiro LC;
    Am J Respir Crit Care Med; 2023 Jul; 208(2):188-195. PubMed ID: 37099412
    [No Abstract]   [Full Text] [Related]  

  • 10. Are risk predicting models useful for estimating survival of patients with rheumatoid arthritis-associated interstitial lung disease?
    Nurmi HM; Purokivi MK; Kärkkäinen MS; Kettunen HP; Selander TA; Kaarteenaho RL
    BMC Pulm Med; 2017 Jan; 17(1):16. PubMed ID: 28086844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple dyspnoea scale as part of the assessment to predict outcome across chronic interstitial lung disease.
    Khadawardi H; Mura M
    Respirology; 2017 Apr; 22(3):501-507. PubMed ID: 27862639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Brazilian Portuguese version of the University of California San Diego Shortness of Breath Questionnaire in patients with interstitial lung disease.
    Silva H; Mantoani LC; Zamboti CL; Aguiar WF; Ries AL; Gonçalves AFL; Silva TGD; Ribeiro M; Pitta F; Camillo CA
    J Bras Pneumol; 2021; 47(6):e20210172. PubMed ID: 34932719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exertional hypoxemia is more severe in fibrotic interstitial lung disease than in COPD.
    Du Plessis JP; Fernandes S; Jamal R; Camp P; Johannson K; Schaeffer M; Wilcox PG; Guenette JA; Ryerson CJ
    Respirology; 2018 Apr; 23(4):392-398. PubMed ID: 29193512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung disease.
    Natalini JG; Swigris JJ; Morisset J; Elicker BM; Jones KD; Fischer A; Collard HR; Lee JS
    Respir Med; 2017 Jun; 127():1-6. PubMed ID: 28502413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual analogue scales for interstitial lung disease: a prospective validation study.
    Yates H; Adamali HI; Maskell N; Barratt S; Sharp C
    QJM; 2018 Aug; 111(8):531-539. PubMed ID: 29788503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurophysiological mechanisms of exertional dyspnoea in fibrotic interstitial lung disease.
    Schaeffer MR; Ryerson CJ; Ramsook AH; Molgat-Seon Y; Wilkie SS; Dhillon SS; Mitchell RA; Sheel AW; Khalil N; Camp PG; Guenette JA
    Eur Respir J; 2018 Jan; 51(1):. PubMed ID: 29348183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frailty as a Predictor of Mortality in Patients With Interstitial Lung Disease Referred for Lung Transplantation.
    Montgomery E; Macdonald PS; Newton PJ; Chang S; Jha SR; Hannu MK; Thomson C; Havryk A; Malouf M
    Transplantation; 2020 Apr; 104(4):864-872. PubMed ID: 31397799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
    Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
    Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability, validity and responsiveness to change of the Saint George's Respiratory Questionnaire in early diffuse cutaneous systemic sclerosis.
    Wallace B; Kafaja S; Furst DE; Berrocal VJ; Merkel PA; Seibold JR; Mayes MD; Khanna D
    Rheumatology (Oxford); 2015 Aug; 54(8):1369-79. PubMed ID: 25667436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship of dyspnoea to function and quality of life in systemic sclerosis.
    Baron M; Sutton E; Hudson M; Thombs B; Markland J; Pope J; Robinson D; Jones N; Docherty P; Abu-Hakima M; LeClercq S; Smith D; Mathieu JP
    Ann Rheum Dis; 2008 May; 67(5):644-50. PubMed ID: 17728334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.